Doctors are now able to transplant hepatitis C-infected kidneys and then cure the disease.
It was a daring experiment aimed at expanding the supply of donor organs: Transplant kidneys infected with hepatitis C into uninfected patients, then give them a powerful new drug to banish the virus.
The insidious virus was eradicated in all the kidney transplant recipients — 10 each at Penn and Hopkins — with a 12-week course of Zepatier. The maker, Merck, donated its $55,000 drug.
“I’m really excited by these results,” said Penn kidney transplant specialist Peter P. Reese, who co-led the trailblazing effort with Penn liver transplant specialist David S. Goldberg. “My life’s mission is to help people get more transplants, because there’s such a shortage.”
Read full article: Surgeons transplant hep C-infected kidneys, then cure the virus
|Read Full Article: Surgeons transplant hep C-infected kidneys, then cure the virus|